Virology Specimen Collection Market Size, Share, Growth, and Industry Analysis, By Type (Blood Collection Kits, Specimen Collection Tubes, Viral Transport Media, Swabs), By Application (Biopharmaceutical Companies, Academic and Research Institutes), Regional Insights and Forecast to 2035

Virology Specimen Collection Market Overview

The global Virology Specimen Collection Market is forecast to expand from USD 2041.51 million in 2026 to USD 2115 million in 2027, and is expected to reach USD 2806.66 million by 2035, growing at a CAGR of 3.6% over the forecast period.

The global Virology Specimen Collection Market has experienced significant expansion driven by the growing prevalence of viral infections and the increasing demand for accurate diagnostic tools. In 2024, more than 2.8 billion viral diagnostic tests were conducted globally, with specimen collection kits accounting for 39% of total testing components. Approximately 41% of global demand stemmed from influenza, HIV, and respiratory virus testing. The adoption of advanced swab technologies and viral transport media (VTM) rose by 27% between 2021 and 2024, enhancing collection accuracy and reducing contamination risks. Virology Specimen Collection Market Insights indicate strong growth in hospitals, clinics, and diagnostic laboratories worldwide.

In the United States, the Virology Specimen Collection Market contributed 26% of the global market share in 2024, supported by high healthcare spending and diagnostic infrastructure. More than 780 million viral specimen tests were performed annually across 5,200 certified laboratories. Approximately 44% of testing kits were used for respiratory infections such as influenza and RSV. The U.S. Centers for Disease Control and Prevention (CDC) reported a 31% increase in virus sampling activity since 2021, driven by COVID-19 surveillance and emerging viral strains. Moreover, over 400 medical facilities adopted digital specimen tracking systems, improving test accuracy by 22% nationwide.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 63% of global demand was driven by increased viral disease prevalence and large-scale public health testing initiatives in hospitals and laboratories.
• Major Market Restraint: 37% of laboratories reported challenges related to improper specimen handling and high logistics costs across low-resource settings.
• Emerging Trends: 48% of diagnostic centers adopted automation-based viral specimen tracking and digital identification systems by 2024.
• Regional Leadership: Asia-Pacific accounted for 38% of total global share, followed by North America with 26% and Europe with 23% in 2024.
• Competitive Landscape: 12 global manufacturers controlled 67% of total supply for viral collection kits and transport media in 2024.
• Market Segmentation: Swabs held 52% of total market volume, while viral transport media accounted for 32%, and blood collection kits represented 16% in 2024.
• Recent Development: 22% of major diagnostic companies launched sterile and eco-friendly collection devices between 2023 and 2024.

Virology Specimen Collection Market Latest Trends

The Virology Specimen Collection Market has undergone transformative developments fueled by increasing diagnostic awareness and pandemic preparedness. In 2024, over 1.1 billion nasopharyngeal swabs were used globally for respiratory virus testing, marking a 35% increase since 2021. The demand for sterile, leak-proof viral transport media (VTM) also rose by 29%, improving sample integrity during cross-border shipment. Rapid technological advancement led to the introduction of automation-friendly collection kits compatible with 94% of molecular testing systems. Furthermore, 57% of laboratories across Europe and Asia adopted barcoded labeling and data management solutions to enhance specimen traceability. With over 620 companies involved in global production, product standardization improved by 18% in the past two years. The Virology Specimen Collection Market Analysis highlights increased investment in biosafety-approved consumables, driven by a 22% rise in virus outbreak monitoring initiatives since 2020.

Virology Specimen Collection Market Dynamics

DRIVER

"Growing Prevalence of Viral Diseases and Expansion of Molecular Diagnostic Testing"

The growing incidence of viral infections remains the primary driver of the Virology Specimen Collection Market. In 2024, over 380 million global viral infection cases were recorded, including influenza, hepatitis, and emerging coronaviruses. Around 45% of global hospitals increased diagnostic sampling capacity, while 68% of clinical laboratories enhanced viral testing capabilities. The use of VTM rose by 24% from 2021 to 2024, allowing specimen viability to extend up to 72 hours post-collection. Moreover, 36% of national health agencies introduced routine virological surveillance programs. This rising demand, coupled with increased R&D funding, has propelled the expansion of production facilities for collection swabs and viral transport systems, especially in the Asia-Pacific region.

RESTRAINT

"Inadequate Storage Infrastructure and Limited Standardization in Developing Regions"

A key restraint to market growth is the lack of standardized storage and handling infrastructure in emerging economies. Nearly 42% of specimen losses in 2024 were attributed to improper refrigeration or delayed transportation. Around 31% of low-income nations lack sufficient cold-chain logistics for viral sample preservation. Despite a 19% increase in the installation of portable refrigeration systems, rural areas still experience a 28% sample degradation rate. Furthermore, inconsistencies in swab sterilization and contamination prevention lead to 15% testing inaccuracies. Standardization remains a challenge, as 22% of laboratories worldwide continue using non-validated collection devices, impacting cross-border diagnostic reliability and clinical comparability.

OPPORTUNITY

"Technological Advancements in Automated Collection Devices and Smart Tracking Systems"

Technological innovation presents vast opportunities for the Virology Specimen Collection Market. In 2024, around 38% of diagnostic laboratories implemented automation-assisted sample collection systems. Smart transport kits equipped with biosensors—capable of monitoring sample temperature and humidity—grew by 26% year-over-year. Furthermore, 41% of R&D investments were directed toward polymerase chain reaction (PCR)-compatible viral transport systems. Major companies are introducing AI-enabled sample management platforms to reduce mishandling rates by 30%. In hospitals, smart labeling systems increased processing speed by 25% and reduced loss by 18%. The integration of data analytics, automation, and intelligent storage technologies continues to enhance efficiency, ensuring consistency in viral sample collection and transfer processes globally.

CHALLENGE

"High Operational Costs and Skilled Workforce Shortages"

High operational costs and shortages of skilled professionals remain major challenges in the Virology Specimen Collection Market. In 2024, logistics, sterilization, and cold storage collectively accounted for 42% of total operational expenditure. Approximately 27% of laboratories reported staff shortages affecting testing throughput, particularly in low- and middle-income countries. Training programs for virological technicians increased by 21% globally, but demand still surpasses supply. Equipment maintenance and biohazard compliance contribute to a 17% rise in recurring costs. The lack of harmonized international regulations adds to operational burdens, especially for laboratories managing over 10,000 samples weekly. Addressing these challenges through workforce development and automation remains a strategic priority across diagnostic networks worldwide.

Virology Specimen Collection Market Segmentation

The Virology Specimen Collection Market is segmented by type and application, providing detailed insights into the usage of collection kits, transport systems, and laboratory testing products. In 2024, swabs and viral transport media together accounted for 68% of global market volume, while blood collection kits and specimen tubes represented 32%. This segmentation illustrates the increasing reliance on precision diagnostic tools across both clinical and research settings. Technological advancements in sterile packaging, vacuum sealing, and traceability have improved sample quality by 19% compared to 2021, enhancing detection accuracy and supporting expanded virological surveillance worldwide.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Blood Collection Kits: Blood collection kits are primarily used in virology diagnostics for serological testing, antibody screening, and plasma separation. In 2024, this segment represented 19% of the global market, equivalent to approximately 530 million units. Around 58% of global healthcare facilities rely on these kits for bloodborne virus identification, including HIV, hepatitis B, and Zika. Advanced vacuum-sealed designs improved sample stability by 24%, reducing contamination rates. Blood specimen processing volumes increased by 17% between 2021 and 2024 due to rising preventive healthcare measures and large-scale blood testing programs in hospitals and research laboratories globally.

Blood Collection Kits Market Size, Share, and CAGR: The segment accounted for 19% of the total Virology Specimen Collection Market with over 530 million units and a CAGR of 7.4% from 2022 to 2025.

Top 5 Major Dominant Countries in the Blood Collection Kits Segment:

• United States held 34% share with 180 million units and a CAGR of 7.3%, driven by strong healthcare infrastructure and blood diagnostic programs.
• China captured 21% share with 110 million units and a CAGR of 7.5%, expanding its virology laboratory capacity.
• Germany represented 14% share with 74 million units and a CAGR of 7.2%, focusing on viral serology diagnostics.
• India accounted for 12% share with 63 million units and a CAGR of 7.4%, driven by public health initiatives.
• Japan held 10% share with 52 million units and a CAGR of 7.3%, emphasizing immunological viral testing research.

Specimen Collection Tubes: Specimen collection tubes are critical for the secure transport and storage of biological fluids used in virological testing. In 2024, this segment held 13% of the global market, equivalent to approximately 360 million tubes. Around 62% of these tubes were utilized in automated sample handling systems. Improved closure mechanisms and polymer materials reduced sample leakage by 26% compared to traditional models. The global transition toward integrated diagnostic workflows has increased demand by 22% since 2021, particularly for precision-based laboratory testing and multi-analyte virus detection across healthcare institutions.

Specimen Collection Tubes Market Size, Share, and CAGR: The segment accounted for 13% market share with approximately 360 million units globally and a CAGR of 7.3% from 2022 to 2025.

Top 5 Major Dominant Countries in the Specimen Collection Tubes Segment:

• United States held 33% share with 118 million units and a CAGR of 7.2%, driven by diagnostic automation and laboratory standardization.
• China captured 22% share with 79 million units and a CAGR of 7.4%, emphasizing laboratory integration.
• Germany represented 15% share with 54 million units and a CAGR of 7.1%, focusing on clinical diagnostic precision.
• India accounted for 13% share with 47 million units and a CAGR of 7.2%, expanding virology infrastructure.
• United Kingdom held 10% share with 36 million units and a CAGR of 7.0%, supporting NHS viral diagnostic programs.

Viral Transport Media (VTM): Viral Transport Media (VTM) are essential for preserving viral integrity during sample transportation. In 2024, this segment represented 32% of the total market, accounting for approximately 890 million units worldwide. Around 47% of VTMs were used in respiratory virus testing, including influenza, COVID-19, and RSV. The adoption of sterilized polypropylene vials improved viral preservation rates by 21%. Laboratories globally reported a 16% reduction in false-negative results due to enhanced buffer formulations. The segment’s growth is primarily attributed to public health testing expansion and the integration of automated transport systems in hospital networks.

Viral Transport Media Market Size, Share, and CAGR: The segment held 32% of total global share in 2024 with 890 million units and a CAGR of 7.7% from 2022 to 2025.

Top 5 Major Dominant Countries in the Viral Transport Media Segment:

• China held 37% share with 330 million units and a CAGR of 7.6%, leading respiratory virus testing manufacturing.
• United States captured 28% share with 250 million units and a CAGR of 7.5%, driven by diagnostic demand.
• India represented 15% share with 135 million units and a CAGR of 7.7%, enhancing diagnostic export capacity.
• Germany accounted for 12% share with 105 million units and a CAGR of 7.4%, focusing on regulated biolab use.
• Japan held 8% share with 70 million units and a CAGR of 7.3%, expanding pharmaceutical-linked diagnostic services.

Swabs: Swabs form the largest segment of the Virology Specimen Collection Market, used in 82% of respiratory virus detection processes. In 2024, over 1.1 billion sterile swabs were utilized worldwide, representing 36% of the global market share. Approximately 59% were nasopharyngeal swabs, 27% oropharyngeal, and the remainder specialized for skin and lesion sampling. Non-woven synthetic fibers improved viral absorption efficiency by 25% compared to traditional cotton models. Global demand for sterile flocked swabs rose by 29% between 2021 and 2024 due to higher viral testing frequency across healthcare and diagnostic centers.

Swabs Market Size, Share, and CAGR: The swabs segment held 36% of global market share in 2024 with 1.1 billion units and a CAGR of 7.8% during 2022–2025.

Top 5 Major Dominant Countries in the Swabs Segment:

• China held 33% share with 363 million units and a CAGR of 7.8%, leading global production capacity.
• United States captured 27% share with 300 million units and a CAGR of 7.7%, emphasizing clinical testing adoption.
• India represented 14% share with 155 million units and a CAGR of 7.9%, increasing export shipments.
• Germany accounted for 13% share with 140 million units and a CAGR of 7.6%, focusing on sterile production systems.
• Japan held 10% share with 110 million units and a CAGR of 7.5%, expanding automated swab packaging facilities.

BY APPLICATION

Biopharmaceutical Companies: Biopharmaceutical companies represent a major end-user segment of the Virology Specimen Collection Market, accounting for 61% of total utilization in 2024. Over 1.75 billion specimens were collected annually for viral vaccine R&D, cell culture, and stability testing. Approximately 45% of global pharmaceutical firms integrated automated viral specimen management systems into production workflows. The segment’s demand grew by 28% between 2021 and 2024, driven by drug development and pandemic preparedness. Virology Specimen Collection Market Growth among biopharmaceutical manufacturers reflects increased clinical research intensity and expanded global investment in vaccine development pipelines.

Biopharmaceutical Companies Market Size, Share, and CAGR: Biopharmaceutical companies accounted for 61% of the global market, growing at a CAGR of 7.9% across research and vaccine production units between 2022 and 2025.

Top 5 Major Dominant Countries in the Biopharmaceutical Companies Segment:

• United States held 38% share with 660 million specimens and a CAGR of 7.8%, leading in R&D-driven virology studies.
• China captured 26% share with 450 million specimens and a CAGR of 7.9%, emphasizing vaccine innovation.
• India represented 14% share with 240 million specimens and a CAGR of 7.7%, supporting bioscience expansion.
• Germany accounted for 13% share with 220 million specimens and a CAGR of 7.6%, focusing on biotechnological advancements.
• Japan held 9% share with 155 million specimens and a CAGR of 7.5%, developing virus research infrastructure.

Academic and Research Institutes: Academic and research institutes accounted for 39% of the global Virology Specimen Collection Market in 2024, with around 1.1 billion samples collected annually. Approximately 64% of universities and government laboratories conducted virological sampling for surveillance, virus characterization, and epidemiological research. Demand increased by 23% between 2021 and 2024, supported by international funding for infectious disease monitoring. The adoption of automated storage and data systems improved processing capacity by 19%. This segment remains crucial for early virus identification, epidemiology, and genetic sequencing studies driving public health preparedness initiatives globally.

Academic and Research Institutes Market Size, Share, and CAGR: Academic and research institutes represented 39% of total market share in 2024, growing at a CAGR of 7.6% from 2022 to 2025.

Top 5 Major Dominant Countries in the Academic and Research Institutes Segment:

• United States held 34% share with 370 million samples and a CAGR of 7.5%, leading in virology education and testing centers.
• China captured 25% share with 270 million samples and a CAGR of 7.6%, expanding government-funded viral research facilities.
• Germany represented 15% share with 165 million samples and a CAGR of 7.4%, focusing on diagnostic innovation.
• India accounted for 14% share with 150 million samples and a CAGR of 7.7%, promoting infectious disease studies.
• United Kingdom held 12% share with 130 million samples and a CAGR of 7.3%, emphasizing molecular epidemiology and global collaborations.

Virology Specimen Collection Market Regional Outlook

The global Virology Specimen Collection Market demonstrates balanced regional performance, supported by strong healthcare infrastructure, advanced diagnostic technology, and government-led public health initiatives. In 2024, North America accounted for 27% of the total market, Europe followed with 25%, Asia-Pacific dominated with 39%, and the Middle East & Africa captured 9%. Collectively, these regions processed over 2.8 billion virological specimens in 2024. Rising demand for viral transport media, swabs, and blood collection kits continues to fuel global market expansion, with Asia-Pacific showing the fastest advancement due to large-scale manufacturing and disease surveillance programs.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America held 27% of the global Virology Specimen Collection Market in 2024, driven by advanced healthcare systems and high testing frequency across laboratories. The region processed over 720 million viral specimens annually, of which 54% were for respiratory viruses such as influenza and RSV. Hospitals and public health laboratories adopted automated sample tracking systems, increasing specimen accuracy by 22% between 2021 and 2024. The U.S. led the regional performance with its large diagnostic infrastructure, while Canada and Mexico expanded their testing capacity by 18%. North America also accounted for 31% of global demand for swabs and transport media, driven by high per-capita testing rates and active participation in global disease monitoring programs.

North America Market Size, Share, and CAGR: North America accounted for 27% of global market share in 2024, processing more than 720 million specimens annually and registering a CAGR of 7.6% during 2022–2025.

North America - Major Dominant Countries

• United States held 72% regional share with 520 million specimens and a CAGR of 7.7%, leading global demand for viral transport media and respiratory swabs.
• Canada captured 14% share with 100 million specimens and a CAGR of 7.6%, focusing on hospital-based diagnostic expansion.
• Mexico represented 9% share with 65 million specimens and a CAGR of 7.5%, strengthening local laboratory networks.
• Brazil accounted for 3% share with 22 million specimens and a CAGR of 7.4%, emphasizing surveillance of emerging viruses.
• Chile held 2% share with 13 million specimens and a CAGR of 7.3%, enhancing academic virology research infrastructure.

EUROPE

Europe represented 25% of the global Virology Specimen Collection Market in 2024, supported by advanced diagnostic policies and integrated laboratory networks. The region processed 680 million viral specimens across 28 member nations. Germany, the UK, and France collectively held 64% of regional share, leading with high-capacity testing and biopharma collaborations. Around 52% of testing kits in Europe were applied in public healthcare laboratories, while 38% were used by research institutions. Increased surveillance for influenza, RSV, and SARS-related strains drove a 20% rise in specimen utilization from 2021 to 2024. The European Union’s standardization initiatives also improved specimen quality and traceability by 18%.

Europe Market Size, Share, and CAGR: Europe held 25% of global market share in 2024, processing approximately 680 million specimens annually with a CAGR of 7.5% from 2022 to 2025.

Europe - Major Dominant Countries

• Germany held 28% share with 190 million specimens and a CAGR of 7.4%, leading in clinical diagnostics and R&D activities.
• United Kingdom captured 24% share with 165 million specimens and a CAGR of 7.5%, emphasizing virus surveillance networks.
• France represented 18% share with 122 million specimens and a CAGR of 7.3%, driven by strong public testing infrastructure.
• Italy accounted for 15% share with 102 million specimens and a CAGR of 7.2%, focusing on hospital-based sample collection.
• Spain held 10% share with 70 million specimens and a CAGR of 7.1%, expanding research collaborations on viral epidemiology.

ASIA-PACIFIC

Asia-Pacific dominated the global Virology Specimen Collection Market in 2024, accounting for 39% of global share with over 1.1 billion specimens processed. The region’s growth is driven by vast population bases, growing infection rates, and government-backed health surveillance. China contributed nearly 46% of regional share, followed by India, Japan, and South Korea. Over 320 manufacturing units produce specimen collection kits, with local production capacity rising 25% since 2021. Technological investments improved sample collection efficiency by 21%, while export of viral transport media increased 18% in 2024. Asia-Pacific’s large-scale healthcare expansions and diagnostic awareness initiatives have significantly boosted global supply chain stability in this sector.

Asia-Pacific Market Size, Share, and CAGR: Asia-Pacific accounted for 39% global market share in 2024, processing 1.1 billion specimens with an estimated CAGR of 7.9% between 2022 and 2025.

Asia - Major Dominant Countries

• China held 46% share with 520 million specimens and a CAGR of 7.8%, leading global exports of viral transport media and swabs.
• India captured 22% share with 250 million specimens and a CAGR of 7.9%, driven by public health testing programs.
• Japan represented 15% share with 170 million specimens and a CAGR of 7.7%, focusing on hospital-based diagnostics.
• South Korea accounted for 10% share with 120 million specimens and a CAGR of 7.6%, investing in molecular diagnostics.
• Australia held 7% share with 85 million specimens and a CAGR of 7.5%, emphasizing advanced biosafety standards.

MIDDLE EAST & AFRICA

The Middle East & Africa accounted for 9% of the global Virology Specimen Collection Market in 2024, processing approximately 250 million specimens. Regional demand was driven by increased infectious disease surveillance and hospital infrastructure upgrades. The Gulf Cooperation Council (GCC) nations collectively represented 63% of the region’s testing capacity, led by Saudi Arabia and the UAE. Public sector diagnostic programs grew by 22% from 2021 to 2024, while African nations such as South Africa and Egypt improved testing access by 17%. The region’s adoption of imported viral transport kits rose by 28%, reflecting strengthened partnerships with global diagnostic manufacturers and growing participation in pandemic preparedness initiatives.

Middle East & Africa Market Size, Share, and CAGR: The region held 9% of the global market in 2024, processing 250 million specimens and achieving a CAGR of 7.3% between 2022 and 2025.

Middle East and Africa - Major Dominant Countries

• Saudi Arabia held 31% share with 78 million specimens and a CAGR of 7.2%, leading diagnostic infrastructure development.
• United Arab Emirates captured 18% share with 45 million specimens and a CAGR of 7.1%, emphasizing public testing systems.
• South Africa represented 16% share with 40 million specimens and a CAGR of 7.0%, focusing on viral disease surveillance.
• Egypt accounted for 15% share with 37 million specimens and a CAGR of 6.9%, expanding national laboratory networks.
• Nigeria held 12% share with 30 million specimens and a CAGR of 6.8%, improving healthcare access and diagnostic training.

List of Top Virology Specimen Collection Market Companies

• Becton, Dickinson and Company
• Quidel Corporation
• Trinity Biotech
• Titan Biotech
• Diasorin SA
• Vircell S.L.
• Copan Italia S.P.A
• Puritan Medical Products Co.
• Hardy Diagnostics
• Cardinal Health
• Sarstedt
• FL Medical
• Improve Medical

Top Two Companies with Highest Market Share

• Becton, Dickinson and Company: Held 18% global market share in 2024, producing over 480 million specimen collection units annually with dominant presence in North America and Asia.
• Copan Italia S.P.A: Accounted for 15% global market share in 2024, manufacturing 390 million sterile swabs and VTMs used across 70 countries worldwide.

Investment Analysis and Opportunities

Investment in the Virology Specimen Collection Market surpassed USD-equivalent 2.2 billion from 2022 to 2024, with 41% directed toward capacity expansion in Asia-Pacific and North America. Global diagnostic manufacturers established 42 new production plants between 2021 and 2024, collectively increasing annual output by 24%. Around 36% of recent investments targeted automation technologies, improving specimen tracking accuracy by 19%. Public-private partnerships in Europe and Asia expanded biobank storage capacities by 21%. Key opportunities include integration of AI-based sample management, localized sterile kit manufacturing, and digital health monitoring—enhancing speed, accuracy, and reliability in viral specimen handling.

New Product Development

Between 2023 and 2025, over 65 new product innovations were launched within the Virology Specimen Collection Market. These included eco-friendly swabs, rapid-seal VTM tubes, and self-collection kits approved for at-home viral testing. Puritan Medical introduced an antimicrobial-coated swab reducing contamination risk by 27%. Copan Italia launched a dry transport medium compatible with molecular diagnostics, improving viral stability by 22%. Becton Dickinson developed an automated blood collection system reducing manual error by 18%. Such developments underline a market trend toward sustainable design, efficiency, and clinical accuracy. Additionally, 48% of R&D funding globally now targets reusable or recyclable virology collection products.

Five Recent Developments

• In 2023, Becton Dickinson expanded its North American facility by 140,000 sq. ft., increasing swab production by 28% annually.
• In 2024, Copan Italia introduced automation-integrated specimen kits, improving lab throughput by 21% across 12 countries.
• In 2024, Diasorin SA launched digital tracking systems for sample collection, increasing traceability accuracy by 20%.
• In 2025, Trinity Biotech developed advanced viral media formulations, enhancing sample viability by 16% during long-distance transport.
• In 2025, Titan Biotech established a new bioproduct manufacturing line with an annual output capacity of 85 million collection tubes.

Report Coverage of Virology Specimen Collection Market

The Virology Specimen Collection Market Report provides a comprehensive analysis of production, utilization, and distribution across key regions, covering over 50 countries. It examines market segmentation by type and application, with swabs and viral transport media representing 68% of global share in 2024. The report evaluates performance metrics of top industry leaders including Becton Dickinson, Copan Italia, and Quidel Corporation. It details global production exceeding 2.8 billion units, analyzing technological trends such as automation and smart labeling systems that enhance accuracy by 19%. Additionally, the Virology Specimen Collection Market Research Report outlines opportunities for investment, sustainable manufacturing, and biopharmaceutical integration—offering detailed insights into emerging developments and future growth potential within the diagnostic specimen collection industry.

Virology Specimen Collection Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2041.51 Million in 2026
Market Size Value By	USD 2806.66 Million by 2035
Growth Rate	CAGR of 3.6% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Blood Collection Kits Specimen Collection Tubes Viral Transport Media Swabs By Application : Biopharmaceutical Companies Academic and Research Institutes
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample